À retenir
In 24 children recorded at the same time with the Dormotech wearable system and standard in-laboratory polysomnography, apnea-hypopnea index (AHI) severity classification agreed closely (κ = 0.896) and median AHI did not differ (2.2 vs. 1.3 events/h, p = 0.808). It was tested in a sleep laboratory under supervision, so home performance is still unproven.
Study design
Validation : étude/revue
Reading basis
Published abstract
Reading focus
Reference & error
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sleep tests in children are hard to get, and a wearable system that works at home could widen access if it still captures sleep stages and breathing events. The authors compared a wearable Type 2 sleep-monitoring system with standard in-laboratory polysomnography in children referred for overnight sleep evaluation.
Population et méthode
Validation study of children referred for overnight sleep evaluation, who wore the Dormotech wearable Type 2 system at the same time as in-laboratory polysomnography (Nox A1). Recordings were manually scored by American Academy of Sleep Medicine guidelines. The primary outcomes were AHI and severity classification. Secondary outcomes were global sleep-wake and respiratory parameters, usability and safety. Agreement was assessed with kappa, Bland-Altman analysis and paired comparisons.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 124 children completed supervised recordings and were analysed (median age 10.5 years, interquartile range 8.8-13.3; 50.0% female).
- 2Median AHI was 2.2 events/h (interquartile range 0.9-3.4) with Dormotech and 1.3 (0.6-3.6) with polysomnography, with no significant difference (p = 0.808).
- 3AHI severity classification showed high agreement (κ = 0.896). In the Bland-Altman analysis, the median paired difference (Nox minus Dormotech) was -0.2 events/h, with empirical 95% limits of agreement of -1.9 to 6.7 events/h.
- 4No significant differences were found across secondary sleep or respiratory parameters, user experience was favorable and no device-related adverse events occurred.
Limites et incertitude
- 1Only 24 children were studied, and the median AHI was low in both systems, so the abstract gives little information on performance in children with more severe sleep apnea.
- 2The wide limits of agreement (-1.9 to 6.7 events/h) show that individual children's AHI values could differ noticeably between systems, even though the group medians were similar.
- 3Recordings were made under supervision in a laboratory, not at home, which the authors say needs separate study.
- 4The abstract text is partly garbled in places, so details of the statistics may be missing; this reading is based on the abstract only.
Mise en perspective
This is an early sign that a wearable Type 2 system could stand in for lab polysomnography in children, at least when set up by staff. It does not show the system works when parents apply it at home. Whether a child needs a sleep test, and which one, is a decision for their clinician.
Vos données
This is a clinical sleep test, not something a consumer tracker replicates. Everyday wearables estimate sleep from movement and heart rate and do not measure the breathing events that produce an AHI. If you track a child's sleep, use it for patterns such as bedtime and duration, and see a clinician for snoring or breathing pauses.
Comprendre ce type de preuve
Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Comprehensive Type 2 sleep-monitoring systems designed to support home-based assessment may improve access to pediatric sleep assessment while preserving evaluation of sleep architecture and respiratory events. This study evaluated the clinical performance of a wearable Type 2 sleep monitoring system compared with standard in-laboratory polysomnography in children.
Methods
Children referred for overnight sleep evaluation underwent simultaneous recordings using the Dormotech wearable Type 2 system and in-laboratory polysomnography (Nox A1). Recordings were manually scored according to American Academy of Sleep Medicine guidelines. Primary outcomes were apnea-hypopnea index (AHI) and severity classification; secondary outcomes included global sleep-wake and respiratory parameters, usability, and safety.
Results
Twenty-four children completed supervised in-laboratory recordings and were included in the analysis (median age, 10.5 years; 25th-3.6) events/h with polysomnography ( p = 0.808). AHI severity classification showed high agreement (κ = 0.896), with a med75th percentiles, 8.8-13.3; 50.0% female). Median AHI was 2.2 (25th-75th percentiles, 0.9-3.4) events/h with Dormotech and 1.3 (0.6-3.6) events/h with polysomnography ( p = 0.808). AHI severity classification showed high agreement (κ = 0.896), with a median Bland-Altman paired difference (Nox - Dormotech) of -0.2 events/h and empirical 95% limits of agreement of -1.9 to 6.7 events/h. No significant differences were observed across secondary sleep or respiratory parameters. User experience was favorable, with no device-related adverse events.
Conclusions
The comprehensive Type 2 system demonstrated strong agreement with in-laboratory polysomnography across respiratory and global sleep-wake measures in children. These findings demonstrate agreement under supervised laboratory conditions and provide a foundation for future studies evaluating the system's performance in unsupervised use settings.
Sources et attribution
Advancing Sleep Testing for Children: In-Laboratory Validation of a Type 2 Sleep-Monitoring System Designed for Home-Based Pediatric Assessment.
Fox BD, Shihab M, Kushinsky D, Lanir-Azaria S, Nassir A, Barnea O, Tal A.
Children (Basel, Switzerland) · 2026-10-18
DOI: 10.3390/children13101432 ↗PubMed · 42940751 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

